V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210010070 | 210036407 | 1.72 | 0 | Curative (C) | 2015-08-06 | 2015-08-06 | UKALL14- Ph 1 Induction | 0 | N | 210031468 | UKALL2014 |
| 160025008 | 160035957 | 1.79 | 64.95 | null | 2013-12-25 | 2013-12-29 | BENDAMUSTINE + RITUXIMAB | 0 | N | 160018594 | BENDAMUSTINE + RITUXIMAB |
| 210010276 | 210003239 | 1.93 | 70.1 | Curative (C) | 2016-06-17 | 2016-06-17 | UKALL14- Ph 1 Induction | 0 | N | 210032107 | UKALL2014 |
| 210010492 | 210029093 | null | 77 | Curative (C) | 2013-06-12 | 2013-06-23 | UKALL14- Ph 1 Induction | 0 | N | 210032830 | UKALL2014 |
| 10007341 | 10005189 | 1.72 | 77.9 | Curative (C) | 2015-05-23 | 2015-05-30 | Pazopanib | 0 | N | 10535646 | R-EPOCH |
| 240009744 | 240006155 | null | null | Adjuvant (A) | 2016-05-20 | 2016-05-28 | CHOP R - 21 days | 0 | Y | 240009246 | CHOP R |
| 240009815 | 240006221 | null | null | Curative (C) | 2015-07-05 | 2015-07-21 | Cisplatin 7 day | 0 | Y | 240009671 | CISPLATIN |
| 240009942 | 240006326 | 1.57 | null | Not known (9) | 2017-03-16 | 2017-03-16 | Cisplatin 7 day | 0 | null | 240010421 | CISPLATIN |
| 260009597 | 260015671 | 1.65 | 91 | Curative (C) | 2014-11-27 | 2014-12-02 | Carboplatin + Paclitaxel (3 weekly) | 0 | Y | 260006339 | RITUXIMAB |
| 120008227 | 120004937 | 1.74 | null | Neo-adjuvant (N) | 2013-07-31 | 2013-08-22 | ECX | 0 | Y | 120010105 | ATEZOLIZUMAB |
| 160029632 | 160011737 | 1.49 | null | Disease modification (D) | 2016-04-01 | 2016-05-27 | CHOP R - 21 days | 0 | N | 160003603 | CHOP R |
| 160002704 | 160001488 | 1.85 | 77.7 | Curative (C) | 2013-12-14 | 2013-12-15 | CHOP R | 0 | null | 160004154 | CHOP R |
| 160016155 | 160008815 | 1.58 | null | Adjuvant (A) | 2014-04-22 | 2014-04-22 | DA-EPOCH-R | 0 | N | 160024555 | R-EPOCH |
| 210010258 | 210016588 | 1.75 | 95.3 | Curative (C) | null | 2017-07-20 | UKALL14- Ph 1 Induction | 0 | null | 210032022 | UKALL2014 |
| 160016413 | 160030989 | 1.6 | 83.5 | Curative (C) | 2017-05-24 | 2017-05-24 | DA-EPOCH-R | 0 | null | 160024933 | R-EPOCH |
| 160016599 | 160009070 | 1.58 | null | Curative (C) | 2013-03-03 | 2013-03-04 | R-EPOCH | 0 | N | 160025233 | R-EPOCH |
| 160016832 | 160009196 | 1.85 | 108 | Curative (C) | 2014-12-13 | 2014-12-13 | DA-EPOCH-R | 0 | null | 160025592 | R-EPOCH |
| 160016835 | 160009199 | 1.53 | 59.1 | Curative (C) | 2013-02-20 | 2013-02-28 | CHEMO-T TRIAL | 0 | N | 160025596 | TRIAL |
| 160016893 | 160009236 | null | 47.4 | Curative (C) | 2017-01-02 | 2017-01-02 | DA-EPOCH-R | 0 | N | 160025684 | R-EPOCH |
| 160016927 | 160023703 | 1.62 | 71.2 | Curative (C) | 2016-06-23 | 2016-06-23 | DA-EPOCH-R | 0 | N | 160025736 | R-EPOCH |
| 160000506 | 160000268 | 1.69 | null | Curative (C) | 2014-09-03 | 2014-09-03 | CHOP R - 21 days | 0 | N | 160000792 | CHOP R |
| 160018098 | 160009852 | null | null | Disease modification (D) | 2011-09-09 | 2013-10-03 | Bendamustine + prednisolone | 0 | 0 | 160027553 | BENDAMUSTINE |
| 160018184 | 160009894 | 1.7 | null | Palliative (P) | 2014-01-23 | 2014-01-24 | METHOTREXATE | 0 | N | 160027683 | CARBOPLATIN + PACLITAXEL |
| 160018238 | 160009918 | 1.87 | 72 | Curative (C) | 2013-09-24 | 2013-09-25 | RIALTO TRIAL | 0 | N | 160027765 | CVP |
| 160018442 | 160010037 | 1.78 | 75.7 | Palliative (P) | 2018-06-09 | 2018-06-10 | R-GEM-P | 0 | N | 160028086 | CVD |
| 160018759 | 160037349 | 1.77 | 74 | Disease modification (D) | 2015-04-11 | 2015-04-11 | R-HYPER-CVAD | 0 | N | 160028593 | GEMCITABINE |
| 160018831 | 160010240 | 1.77 | 95 | Curative (C) | 2014-12-30 | 2015-01-03 | MATRIX (lymphoma) | 0 | 0 | 160028708 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 160019205 | 160010436 | null | 62 | Curative (C) | 2018-07-29 | 2018-07-30 | VEDex | 0 | N | 160008525 | MATRIX TRIAL |
| 160019336 | 160010512 | 1.7 | 85 | Palliative (P) | 2014-08-31 | 2014-09-06 | Bortezomib (weekly) | 0 | N | 160016386 | DHAP |
| 160020264 | 160011261 | 1.76 | 66.9 | Curative (C) | 2017-04-04 | 2017-04-12 | CHOP R | 0 | 0 | 160001848 | CHOP R |
| 160021288 | 160012361 | null | null | null | 2015-08-28 | 2015-08-29 | CHOP R | 0 | null | 160005526 | CHOP R |
| 160021385 | 160012456 | 1.78 | null | Curative (C) | 2015-11-29 | 2015-11-29 | CHOP R - 21 days | 0 | N | 160005858 | CHOP R |
| 160024651 | 160035896 | null | 99 | Curative (C) | 2014-03-30 | 2014-03-30 | Methotrexate High Dose (3g/m2) | 0 | null | 160017362 | METHOTREXATE HIGH DOSE |
| 160024686 | 160015442 | 1.61 | 75.5 | Curative (C) | 2013-11-22 | 2013-12-28 | Methotrexate High Dose (3g/m2) | 0 | N | 160017459 | METHOTREXATE HIGH DOSE |
| 160024688 | 160015442 | 1.65 | null | Curative (C) | 2016-11-17 | 2016-11-18 | Bendamustine+Rituximab(Sub Courses) | 0 | null | 160017459 | BENDAMUSTINE + RITUXIMAB |
| 160024876 | 160037781 | null | 91 | null | 2016-05-31 | 2016-05-31 | Bendamustine+Rituximab(Sub Courses) | 0 | N | 160018138 | BENDAMUSTINE + RITUXIMAB |
| 160024962 | 160015640 | null | 81 | Palliative (P) | 2015-10-02 | 2015-10-02 | BENDAMUSTINE + RITUXIMAB | 0 | N | 160018448 | BENDAMUSTINE + RITUXIMAB |
| 160024985 | 160039767 | 1.52 | 75.8 | Curative (C) | 2017-01-12 | 2017-01-13 | Bendamustine+Rituximab (1st Course) | 0 | N | 160018511 | BENDAMUSTINE + RITUXIMAB |
| 160017259 | 160009415 | null | 112 | Disease modification (D) | 2017-10-23 | 2017-10-25 | IBRUTINIB | 0 | N | 160026257 | IBRUTINIB |
| 160026577 | 160016903 | 1.77 | 81 | Curative (C) | 2013-06-21 | 2013-06-22 | DA-EPOCH-R | 0 | null | 160023227 | R-EPOCH |
| 160039139 | 160019730 | null | null | Curative (C) | 2020-06-17 | 2020-07-17 | ALL Int GdeC D Int PhIV recon Pasp | 0 | N | 160006218 | FLUDARABINE |
| 160029641 | 160024806 | null | null | null | 2015-09-02 | 2015-09-03 | CHOP R | 0 | null | 160003667 | CHOP R |
| 160031183 | 160014905 | 1.75 | 86.2 | Palliative (P) | 2013-04-02 | 2013-05-27 | Methotrexate High Dose (3g/m2) | 0 | N | 160015108 | METHOTREXATE HIGH DOSE |
| 160032414 | 160033101 | 1.79 | 89 | Curative (C) | 2017-10-22 | 2017-10-31 | R-EPOCH | 0 | N | 160022808 | R-EPOCH |
| 160034141 | 160031367 | 1.84 | null | Curative (C) | 2014-09-05 | 2014-10-03 | CHOP R | 0 | null | 160000149 | CHOP R |
| 160035065 | 160026245 | null | null | Palliative (P) | 2017-05-10 | 2017-05-10 | BENDAMUSTINE + RITUXIMAB | 0 | N | 160014211 | BENDAMUSTINE + RITUXIMAB |
| 160035133 | 160014875 | 1.71 | null | Palliative (P) | 2015-07-27 | 2015-12-08 | Methotrexate High Dose (3g/m2) | 0 | N | 160014975 | METHOTREXATE HIGH DOSE |
| 160036962 | 160011729 | null | null | Curative (C) | 2016-05-09 | 2016-06-05 | CHOP R - 21 days | 0 | null | 160003569 | CHOP R |
| 160037294 | 160026240 | null | 87.2 | Curative (C) | 2017-12-10 | 2017-12-13 | Methotrexate High Dose (3g/m2) | 0 | N | 160014204 | METHOTREXATE HIGH DOSE |
| 160016177 | 160008827 | null | null | Curative (C) | 2014-10-09 | 2014-10-14 | DA-EPOCH-R | 0 | N | 160024585 | R-EPOCH |